✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Axsome Therapeutics Inc

Common Name
Axsome Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
1,220
Ticker
AXSM
Exchange
NASDAQ/NMS
Description
Axsome Therapeutics is a commercial-stage biopharmaceutical company specializing in the development and commercialization of small-molecule medicines and novel therapies targeting central nervous syst...

Disclosures of Axsome Therapeutics

Explore Axsome Therapeutics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Axsome Therapeutics's official channels and fully traceable to its official company sources.

The table below lists all of Axsome Therapeutics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20242 disclosures
Financial & Extra-Financial Disclosure
10-K
en
20232 disclosures
10-K
en
Financial & Extra-Financial Disclosure
20221 disclosure
10-K
20211 disclosure
10-K
20201 disclosure
10-K
20191 disclosure
10-K
20181 disclosure
10-K
20171 disclosure
10-K
20161 disclosure
10-K
20151 disclosure
10-K
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?